Infliximab is a purified, recombinant DNA-derived chimeric human-mouse IgG monoclonal antibody that blocks TNF-alpha interaction with TNF-alpha receptor 1 (TNFR1) and TNFR2. For the treatment of autoimmune diseases. Infliximab is available in BALB/ C or C57/Bl6 mice.
Molecular Weight:
144188.23
Purity:
>98%
CAS Number:
[170277-31-3]
Formula:
C6428H9912N1694O1987S46
Target:
TNF Receptor
* VAT and and shipping costs not included. Errors and price changes excepted